Header Logo

Connection

SUSAN BLANEY to Risk Factors

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Risk Factors.
SUSAN BLANEY
Connection Strength
0.007
Risk Factors
  1. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2008 Jan 20; 26(3):399-405.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.